Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
about
Antibody-Based Strategies to Prevent and Treat InfluenzaNovel universal influenza virus vaccine approachesBroadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies.Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection.Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.Strategies to induce broadly protective antibody responses to viral glycoproteins.Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.Elicitation of protective antibodies against a broad panel of H1N1 viruses in ferrets pre-immune to historical H1N1 influenza viruses.1st Workshop of the Canadian Society for Virology.Universal influenza virus vaccines: what can we learn from the human immune response following exposure to H7 subtype viruses?Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin.Age and Influenza-Specific Pre-Vaccination Antibodies Strongly Affect Influenza Vaccine Responses in the Icelandic Population whereas Disease and Medication Have Small Effects.Glycosylation of Human IgA Directly Inhibits Influenza A and Other Sialic-Acid-Binding Viruses.Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccineDesign of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine developmentClinical Advances in Viral-Vectored Influenza VaccinesImmunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice
P2860
Q26798520-4A6F3FF9-20C9-468C-A8D7-2E5EA0337609Q30385071-2E0C79A7-ED6C-4473-9712-F030C6C9A5CCQ30393724-6CAEFE55-E37B-4467-A8D6-318E7AA908C3Q30400230-86EA0D27-9DE2-4F87-9678-2C5F6F727370Q34520430-8F1835E1-EFD1-475A-83C6-37DC5535AD45Q36030772-FBA12FF8-5220-4CC9-AEDC-54745266225CQ36434265-349D71C4-D5B8-409A-AE10-B7C72CDD92DBQ36496580-DE4EB5DD-0375-4AB4-8B67-6264E9E07073Q37067663-44F33BBB-436C-4C11-9A7E-543462FB5814Q37323172-B4C37F6C-B1D8-48EB-A7F7-D8D70727A334Q37369509-775B7A77-3995-452F-A83B-7AFCD32FDD58Q39170802-927296FF-5435-4865-B322-4D7724ED8899Q41919718-34369866-AD7B-46B1-A48E-D03ACC93F833Q41924168-5179209B-CC4E-4CBE-97F7-2E119F685911Q42370476-8D9B56EE-48BC-42B9-8687-FA2A4B58D64AQ45324518-9E151E46-4C78-4E27-8E8C-60CDCBF84DFAQ45325556-A1870541-778C-4B58-9DB3-5BBECB46AC36Q47550139-D8450C2D-40BF-4FAF-9AD5-F8AFE0A4F55FQ52332235-7568EAFD-CA24-41F9-A66A-CB61A8ABC1D4Q52649839-2C4A54C9-0EDA-4854-A7DA-70E3974D7C95Q55518397-99790C59-D673-4A7F-9885-35357422448DQ56989454-D1883344-2DC2-4DB1-8958-BF62C0D33FF2Q57094593-F2F56669-B922-48B2-95F2-D4E1E63F349DQ57094631-7D957D61-1AFD-4333-96C3-7B744FE17B57Q57469949-1D09C73E-DB8B-4C78-9898-F6C7EA4ADD87
P2860
Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Broadly neutralizing anti-infl ...... al mixtures and IgA backbones.
@ast
Broadly neutralizing anti-infl ...... al mixtures and IgA backbones.
@en
type
label
Broadly neutralizing anti-infl ...... al mixtures and IgA backbones.
@ast
Broadly neutralizing anti-infl ...... al mixtures and IgA backbones.
@en
prefLabel
Broadly neutralizing anti-infl ...... al mixtures and IgA backbones.
@ast
Broadly neutralizing anti-infl ...... al mixtures and IgA backbones.
@en
P2093
P2860
P356
P1433
P1476
Broadly neutralizing anti-infl ...... al mixtures and IgA backbones.
@en
P2093
Caitlin E Mullarkey
J Andrew Duty
Thomas M Moran
Wenqian He
P2860
P304
P356
10.1128/JVI.03099-14
P577
2015-01-14T00:00:00Z